Journal article
Direct oral anticoagulants after bariatric surgery—What is the evidence?
Abstract
BACKGROUND: Obesity is a global epidemic and bariatric surgery is used with increasing frequency to treat its complications. The extent to which bariatric surgery alters the efficacy, safety, and pharmacokinetics of direct oral anticoagulants (DOACs) is unknown.
AIMS: In this review, we summarize the evidence supporting the use of DOACs after bariatric surgery and apply our findings to resolve several clinical cases.
Authors
Leong R; Chu DK; Crowther MA; Mithoowani S
Journal
Journal of Thrombosis and Haemostasis, Vol. 20, No. 9, pp. 1988–2000
Publisher
Elsevier
Publication Date
9 2022
DOI
10.1111/jth.15823
ISSN
1538-7933